GlassScriptPhysician profile
Michael P Donahue
NPI 1427031962
$96,320.53
in general payments reported to CMS, 2019-2025
39 companies · $12K in 2025
The $12K reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $54K · 2021: $2,206 · 2022: $8,639 · 2023: $5,506 · 2024: $645 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $2,761 · Travel and Lodging: $29.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,200.00 |
| Food and Beverage | $2,761.04 |
| Travel and Lodging | $29.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgalign Spine Technologies, INC. | $66,920.88 | 2019-2022 | |
| Stryker Corporation | $19,283.98 | 2019-2025 | Everest Spinal System, Mojave Expandable Interbody System, Cascadia Interbody System |
| Intrinsic Therapeutics | $3,097.04 | 2022-2025 | Barricaid Acd (Annular Closure Device) |
| Centinel Spine, LLC | $2,278.00 | 2020-2024 | Prodisc L, Prodisc C Vivo |
| Medtronic, INC. | $752.31 | 2021-2025 | Aquamantys(Tm), Adaptix Interbody System With Titan Nanolock Surface Technology, Graftonand Grafton Plusdemineralized Bone Matrix (Dbm) |
| Nevro Corp. | $574.26 | 2019-2024 | Senza |
| Vertiflex, INC. | $349.29 | 2019 | |
| Saluda Medical Americas, INC. | $301.60 | 2023-2025 | Evoke, Evoke Scs |
| Innovasis INC | $276.72 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $217.31 | 2019-2025 | Euflexxa |
| Si-Bone, INC. | $195.78 | 2022-2025 | |
| Pacira Therapeutics, INC. | $188.47 | 2019-2021 | |
| Globus Medical, INC. | $186.11 | 2025 | Vyrsa V1, Senza, Continental |
| Nanohive Medical LLC | $157.50 | 2024-2025 | Hive Standalone Cervical System |
| Supreme Orthopedic Systems, LLC | $152.39 | 2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $144.07 | 2019-2022 | |
| Smith+Nephew, INC. | $120.74 | 2021-2024 | Pico 7 |
| Augmedics INC. | $112.70 | 2021 | |
| Fidia Pharma USA INC. | $109.06 | 2022-2025 | Hyalgan, Triluron, Hymovis |
| Boston Scientific Corporation | $105.22 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Zimmer Biomet Holdings, INC. | $96.57 | 2019-2024 | Tapestry |
| Orthofix Medical, INC. | $95.20 | 2020-2025 | Cervical-Stim |
| Integrity Implants INC. | $88.57 | 2019 | |
| Sanara Medtech INC. | $77.78 | 2022 | |
| Bsn Medical INC | $59.27 | 2022 | |
| Medtronic USA, INC. | $52.04 | 2019 | |
| Orthogenrx INC. | $51.49 | 2019 | |
| Djo, LLC | $49.92 | 2023-2025 | Cmf |
| Vertex Pharmaceuticals Incorporated | $40.03 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $36.49 | 2025 | Iovera, Zilretta, Exparel |
| Spineology INC. | $27.88 | 2022 | |
| Sanofi-Aventis U.S. LLC | $20.88 | 2022 | |
| Convatec INC. | $19.17 | 2021 | |
| Pinnacle, INC | $16.49 | 2021 | |
| Mimedx Group, INC. | $16.46 | 2024 | |
| Pfizer INC. | $16.19 | 2020 | |
| Radius Health, INC. | $13.11 | 2019 | |
| Horizon Therapeutics Plc | $11.76 | 2020 | |
| Advanced Oxygen Therapy INC. | $7.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Donahue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.